WebMD Health Corp. Given Average Rating of “Buy” by Analysts (NASDAQ:WBMD)
Shares of WebMD Health Corp. (NASDAQ:WBMD) have received a consensus rating of “Buy” from the nine analysts that are currently covering the company, American Banking and Market News reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, three have issued a buy rating and two have given a strong buy rating to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $56.68.
In other WebMD Health Corp. news, Director Mark J. Md Adler sold 2,334 shares of WebMD Health Corp. stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $49.16, for a total transaction of $114,739.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Shares of WebMD Health Corp. (NASDAQ:WBMD) remained flat at $48.36 during trading on Wednesday. The stock had a trading volume of 95,260 shares. WebMD Health Corp. has a 52 week low of $28.03 and a 52 week high of $53.30. The stock has a 50-day moving average of $48.91 and a 200-day moving average of $45.53. The company has a market cap of $1.843 billion and a price-to-earnings ratio of 71.12.
WebMD Health Corp. (NASDAQ:WBMD) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.23 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.19 by $0.04. The company had revenue of $140.40 million for the quarter, compared to the consensus estimate of $139.95 million. During the same quarter last year, the company posted $0.05 earnings per share. WebMD Health Corp.’s revenue was up 12.1% compared to the same quarter last year. Analysts expect that WebMD Health Corp. will post $0.97 EPS for the current fiscal year.
WBMD has been the subject of a number of recent research reports. Analysts at Zacks downgraded shares of WebMD Health Corp. from an “outperform” rating to a “neutral” rating in a research note on Tuesday. They now have a $55.10 price target on the stock. Separately, analysts at Stifel Nicolaus reiterated a “positive” rating on shares of WebMD Health Corp. in a research note on Monday, August 25th. They now have a $60.00 price target on the stock. Finally, analysts at Raymond James reiterated a “strong-buy” rating on shares of WebMD Health Corp. in a research note on Wednesday, August 6th. They now have a $57.00 price target on the stock, up previously from $54.00.
WebMD Health Corp. is a provider of health information services to consumers, physicians and other healthcare professionals, employers and health plans through its public and private online portals, mobile platforms and health-focused publications.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.